The intra-aortic balloon (IAB) is an minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart function.
During FDA testing, the new balloon was subject to extensive reliability testing and successfully demonstrated a life of over eight million cycles, which equates to more than 90 days of continuous operation. The 8F IAB is inserted percutaneously into a patient’s descending aorta and inflates and deflates in counterpulsation to a patient’s heart rhythm.
August 14, 2023 
